WT | APP/PS1 | |||
---|---|---|---|---|
FTS•B (mg/kg) | ||||
10 | 40 | |||
TLR3 (ug/g prot) | 30.7 ± 2.9 | 22.7 ± 1.9## | 27.6 ± 2.8* | 28.3 ± 2.3* |
p-IRF3/IRF3 | 0.2 ± 0.0 | 0.2 ± 0.0# | 0.5 ± 0.1* | 0.5 ± 0.1*** |
IFN-β (ng/g prot) | 30.7 ± 3.7 | 17.3 ± 2.5# | 23.4 ± 4.1 | 26.4 ± 1.9* |
JIP3 (ng/g prot) | 81.4 ± 17 | 171.8 ± 35.2# | 59.6 ± 21.3* | 53.8 ± 10.6** |
p-JNK/JNK | 7.1 ± 0.6 | 10 ± 1.0# | 5.6 ± 1.1* | 5.7 ± 0.7** |
p-APP/APP | 0.3 ± 0.0 | 0.6 ± 0.1# | 0.2 ± 0.1** | 0.2 ± 0.0** |
Aβ (mg/g prot) | 1.1 ± 0.1 | 1.5 ± 0.1## | 0.9 ± 0.1*** | 1.2 ± 0.1** |
TNF-α (ng/g prot) | 2.1 ± 0.1 | 2.3 ± 0.1# | 1.7 ± 0.1*** | 1.8 ± 0.1** |
IL-1β (ng/g prot) | 68.4 ± 8.1 | 113.6 ± 13.1## | 82.5 ± 10.8* | 75.4 ± 6.4** |
IL-6 (ng/g prot) | 176.7 ± 4.3 | 215.7 ± 8.3### | 171.2 ± 8.4*** | 170.4 ± 9.8** |
IL-8 (ng/g prot) | 96 ± 15.1 | 177.5 ± 28.1# | 96.2 ± 18.5* | 105.5 ± 9.1 |
IL-12 (ng/g prot) | 37.6 ± 3.0 | 56 ± 5.3# | 29.7 ± 5.6** | 29 ± 4.2** |